Physician profile
Lee J Stone
NPI 1073584314
$2,996.39
in general payments reported to CMS, 2019-2025
22 companies · $29.12 in 2025
The $29.12 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $656 · 2020: $28.94 · 2021: $33.51 · 2022: $654 · 2023: $914 · 2024: $680 · 2025: $29.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,623.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,066.10 | 2019-2025 | Skyrizi, Mavyret, Rinvoq |
| Pfizer INC. | $342.90 | 2019-2024 | |
| Lilly USA, LLC | $180.48 | 2023-2024 | Omvoh |
| Ferring Pharmaceuticals INC. | $171.73 | 2019-2023 | Rebyota |
| Takeda Pharmaceuticals U.S.A., INC. | $170.18 | 2019-2023 | Entyvio |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $142.70 | 2019-2023 | Xifaxan, Plenvu |
| Regeneron Healthcare Solutions, INC. | $133.23 | 2023-2024 | Dupixent |
| Celgene Corporation | $131.86 | 2023-2024 | Zeposia |
| Boston Scientific Corporation | $99.38 | 2019 | |
| Genzyme Corporation | $95.37 | 2023 | |
| Janssen Scientific Affairs, LLC | $92.00 | 2023 | |
| Janssen Biotech, INC. | $90.13 | 2023-2024 | Stelara |
| Allergan, INC. | $48.76 | 2019 | |
| Merck Sharp & Dohme LLC | $45.20 | 2019-2022 | |
| Gilead Sciences, INC. | $34.20 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $29.99 | 2023-2024 | Ibsrela |
| Intercept Pharmaceuticals, INC. | $29.01 | 2019-2022 | |
| Tersera Therapeutics LLC | $27.67 | 2022 | |
| Shionogi INC | $18.13 | 2019 | |
| Exact Sciences Corporation | $16.47 | 2023 | Cologuard Collection Kit |
| Medtronic, INC. | $16.11 | 2021 | |
| Braintree Laboratories, INC. | $14.79 | 2024 | Suflave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.